Artificial intelligence in cancer diagnostics - between hope, realism, and ethical challenges
Artificial Intelligence (AI) is often mentioned as the solution to many of our future challenges, also within healthcare, and in January 2020 the Norwegian Government launched a National Strategy for Artificial Intelligence. What role could AI play in cancer diagnostics? How should diagnoses be set in the future, and which new questions might arise when introducing new technologies?
At Litteraturhuset this evening, Mattijs Elschot from the Digital Life project PROVIZ, Helga Brøgger, Rune Nydal, and Marit Solbjør will discuss possibilities and ethical questions related to AI in cancer research.
AI may be explained as systems that can read and analyse data, make decisions, and produce physical or digital actions in order to reach a certain goal. AI has a wide range of application areas, such as autonomous vehicles, control-functions in digital bank solutions, and automatic face recognition. Within medicine, AI can be used in medical software, and also for object discrimination in images - like tumor identification.
The meeting is organized by PROVIZ and the Department for Public Health and Nursing, NTNU, and will be held in Norwegian.
More information at the web page of Litteraturhuset.